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Abstract
Background: A number of prior studies have examined the association between anthropometric measures and
mortality, but studies investigating the sex-specific predictive value of novel anthropometric measures on mortality
are scarce so far. Therefore, we investigated the sex-specific relevance of the new anthropometric measures body
adiposity index (BAI) and waist to height ratio (WHtR) as well as the common measures body mass index (BMI),
waist circumference (WC), and waist to hip ratio (WHR) for cause-specific mortality risk.
Methods: The analysis was based on data from the German population based KORA (Cooperative Health Research
in the Region of Augsburg) Augsburg cohort study. A total of 6670 men and 6637 women aged 25 to 74 years at
baseline examination were included. During a mean follow-up period of 15.4 years, 2409 persons died. Via Cox
proportional hazard regression, the associations between the different anthropometric measures and all cause-,
cardiovascular disease (CVD)- and cancer mortality were assessed.
Results: BMI, WC, and WHR were significantly associated with all-cause and CVD-mortality in both sexes. WC and
WHR were particularly associated with higher all-cause and CVD-mortality risk in women, while in men especially
WHtR and BAI were strongly related to these outcomes. Females with WC, WHtR, and WHR measures in the 4th
quartile compared with women in the 2nd quartile had a higher risk of death from cancer. Contrary, men in the
lowest quartile of WC and WHtR in comparison to men in the 2nd quartile had a significantly elevated cancer
mortality risk. BAI was no risk predictor for all-cause and cause-specific mortality in women.
Conclusions: Central obesity reflects higher all-cause and CVD-mortality risk particularly in women. BAI and WHtR
seem to be valid as risk predictors for all-cause and especially CVD mortality in men but not women. There are marked
sex-differences regarding cancer mortality risk for the different anthropometric measures.
Keywords: Anthropometric measures, All-cause mortality, Cardiovascular mortality, Cancer mortality, Body adiposity index,
KORA, Obesity, Prospective study
Background
It is well known that obesity is a risk factor for cardio-
vascular and metabolic diseases [1] and also for the
development of certain cancer entities [2]. Furthermore,
the association between body fat and mortality has been
frequently discussed in a number of previous studies [3–9].
Body mass index (BMI) is a measure of obesity that is
widely used, but it is not suited to differentiate between
lean mass and fat mass [10, 11]. It is an important limita-
tion that BMI does not consider the distribution of body
fat, because nowadays it is well known that a number of
diseases and also mortality are more closely related to
visceral fatty tissue accumulation than overall body fatness
[12–15]. Other measures of obesity have been developed
and studied which consider body fat distribution to provide
a better input concerning visceral or central obesity like
waist circumference (WC), waist-to-hip ratio (WHR) and
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waist-to-height ratio (WHtR). Finally, in 2011 a new
measure called “body adiposity index” (BAI) was introduced
to estimate body fat percentage. Prior studies have already
tried to find out the anthropometric measure which is the
best predictor of total and cause-specific mortality [5, 16].
Study results were partially inconsistent regarding the role
of BMI [8]. So far, European studies that investigated the
association between values of novel anthropometric
measures and cause-specific mortality in men and women
are scarce. Thus, the aim of the present study was to deter-
mine which body fat measure was significantly predictive
of all-cause-, CVD- and cancer mortality. To investigate
whether there are sex-specific particularities regarding the
associations, the analysis was conducted separately in men
and women including a sample of the general German
population.
Methods
Study population
Data from the Cooperative Health Research in the Region of
Augsburg (KORA) study which is a prospective population-
based cohort study in Southern Germany were used. In
brief, four independent cross-sectional surveys were
conducted in 1984/85 (Survey (S) 1), 1989/90 (S2),
1994/95 (S3) and 1999/2001 (S4); individuals aged 25
to 64 (S1) / 74 (S2-S3) years were included. For the
present analysis, data from altogether 13,869 partici-
pants of S2, S3, and S4 were available. Data from 562
participants were excluded due to missing values in one
or more of the variables required for the multivariable
analyses. Thus, the final data set consisted of 6670 men
and 6637 women. All subjects were prospectively followed
until 2011, so the maximum observation time was 22 years.
The study design, sampling method and data collection
have been described in detail elsewhere [17]. The study
was approved by the ethics committee of the Bavarian
Medical Association (“Bayerische Landesärztekammer”)
and performed in accordance with the Declaration of
Helsinki. All individuals whose data were included in the
analyses gave their written informed consent to participate
in the study.
Outcome definition
The endpoints considered in our study were overall
mortality and cause-specific mortality (any CVD and
cancer). Mortality was recorded by regularly checking
the vital status of all study participants through the
registration offices inside and outside the study region.
Once the health certificates have been received from the
local health departments, they were coded by a single
trained person using the 9th revision of the International
Classification of Diseases (ICD-9). The coding of the causes
of death was as follows: CVD (ICD-9 390–459, 798), cancer
(ICD-9 140–208), and deaths from any cause (ICD-9 001–
999). The data collection and procedures are described in
more detail elsewhere [18].
Anthropometric measures
We analysed and compared five different anthropometric
measures: Waist circumference was measured at the level
midway between the lower rib margin and the iliac crest in
standing position. Hip circumference was recorded at the
maximum circumference over the buttocks. As further
measures we computed the waist to hip ratio and the waist
to height ratio. BMI was calculated as weight divided by
height squared in kg/m2. The formula used for body
adiposity index was: BAI = [(hip circumference (cm)/height
(m)1.5) − 18] × 100 [19]. All anthropometric measures were
assessed by trained medical staff.
Confounding variables
Information on age, sex, sociodemographic characteris-
tics and medical histories was assessed by standardized
computer-aided interviews. Study participants provided
information on physical activity during leisure time, on
alcohol consumption and smoking status. The leisure
time activity collected separately for summer and winter
has been combined and categorized as active and inactive.
A study participant was considered active if he/she
reported a leisure time activity of at least 1 h per week
in at least one season.
The amount of daily alcohol intake was divided into 3
categories: 0, 0.1 to 19.9, and 20.0 or more g/d for
women; and 0, 0.1 to 39.9, and 40 or more g/d for men.
Smokers were divided into current (occasional or regu-
lar), ex- and never smokers.
Education level was defined as high in case of final
secondary school examination (Abitur or Fachabitur) and
otherwise as low. The variable “survey” forms the basic
examination in which the respective subjects participated
(S2, S3, or S4). The data collection and procedures
regarding standardized medical examinations are described
in more detail elsewhere [17].
Statistical methods
Baseline characteristics in the subgroups were given as
means ± standard deviation (SD) or frequencies (%). For
testing whether there were differences between surviving
and deceased subjects the Wilcoxon signed-rank test as
a nonparametric test was used. Correlations between
anthropometric measures were evaluated with the Pearson
correlation analysis. Cox proportional hazards models
were used to estimate the Hazard ratios (HR) and 95%
confidence intervals (95% CI) for the association between
anthropometric measures and mortality. Proportional
hazards assumptions as a precondition for Cox regression
analysis were tested graphically and in case of uncertainty
also with time-interaction terms. Subjects were divided into
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quartiles of the different anthropometric parameters, separ-
ately for men and women. Then HRs with 95% CIs for total
mortality and also for CVD and cancer mortality were
calculated. Limits of the generated quartiles are shown
in Table 1. In the analysis using the anthropometric
measures as categorized variables, the second quartile
was always used as the reference category. In add-
itional analyses, Cox proportional hazards models have
been performed using the WHO cut-off values for BMI
(18.5–24.99; 25–29.99; > = 30 kg/m2). In this analyses,
persons with an extremely low BMI < 18.5 (n = 86)
were excluded; as reference category the group with a
BMI between 18.5 and 24.99 kg/m2 was used.
Interactions of the anthropometric measures with sex and
age were tested. For the Cox regression model initially the
following variables as potential confounders were consid-
ered: sex, age, survey, education level, alcohol intake,
smoking status and physical activity. As they all showed sig-
nificance in the full model, they were kept in. Traditional
risk factors like blood pressure, blood lipid values and
diabetes were considered as mediators and therefore not
included in the model. For the sub-analyses regarding the
outcomes cancer and CVD mortality we used the same
adjustment variables as mentioned above. Because of the
non-linearity of the associations, cubic smoothing splines
were fitted to the estimated hazard ratios to show the
relationship between different anthropometric measures and
mortality. Confidence bands are given to visualize the uncer-
tainty of the estimations. A p-value of < 0.05 was considered
statistically significant. All statistical analyses were con-
ducted with the software package SAS 9.2 and R 3.3.2.
Results
Baseline characteristics
Of the 13,307 included individuals, 2409 died until 2011.
Of those, 1032 persons died due to CVD (ICD-9390–459,
798), and 791 due to cancer (ICD-9140–208). The mean
observation time was 15.4 years (SD 5.0). Tables 2 and 3
present the baseline characteristics of men and women in
the different mortality groups (total, CVD, and cancer
mortality). Compared to women, men at baseline had a
significantly higher education; they drank significantly
more alcohol, were significantly more often smokers and
had significantly higher blood pressure values (all p-values
< 0.0001). The five anthropometric measures waist
circumference (WC), body mass index (BMI), waist to hip
ratio (WHR), waist to height ratio (WHtR) and body
adiposity index (BAI) were all significantly higher in
subjects who died during follow-up, except for men in the
cancer group. Compared to the total- and the cancer
mortality group, men and women with CVD deaths had
the highest level of serum cholesterol concentrations, were
less physically active and revealed the highest values in all
anthropometric measures. Men and women who died
from cancer had the highest alcohol intake and were more
frequently current smokers. They also had the lowest
values in all anthropometric measures (except BMI in
women) compared to the other mortality groups.
The calculated correlation coefficients between the
anthropometric measures showed high correlation coeffi-
cients, in particular between BMI and BAI, WC, and WHtR
(Table 4).
Anthropometric measures and all-cause mortality
Due to significant interactions with sex in the fully adjusted
model all analyses were stratified by sex. The P values for
interactions between sex and BMI, BAI, WC, WHR, and
WHtR were 0.0662, 0.2669, 0.0002, 0.0001, and 0.0054,
respectively (for outcome total mortality).
In multivariable analysis men and women in the highest
quartile of BMI compared to subjects in the second quartile
had a significantly elevated risk to die from any cause. Men
but not women in the bottom quartile of BMI had also a
higher all-cause mortality risk compared to the second
quartile. Men in the fourth quartile of BAI, WC, and WHR
and men in the first, third and fourth quartile of WHtR
showed a significantly higher all-cause mortality risk in
comparison to the reference group. However, in women a
somewhat different association became apparent: there was
no significant relationship of BAI and all-cause mortality.
Women in the fourth quartile of WHtR and women in the
third and fourth quartile of WC compared to the second
quartile showed a significantly increased total mortality risk.
Regarding WHR, women in the third and fourth quartile
had a strongly elevated risk to die from all-cause in com-
parison to the reference group, whereas the first quartile
had a lower risk (Table 5).
Anthropometric measures and CVD mortality
Regarding CVD mortality, men and women in the highest
quartile of BMI, WHtR, and WHR had a significantly
Table 1 Sex-specific limits of quartiles in anthropometric measures
25th pctl 50th pctl 75 pctl
Men
Waist circumference (cm) 89.00 95.50 102.00
Body mass index (kg/m2) 24.78 26.92 29.39
Waist/height ratio 0.51 0.55 0.59
Waist/hip ratio 0.88 0.93 0.97
Body adiposity index 24.76 26.92 29.30
Women
Waist circumference (cm) 74.00 82.00 91.00
Body mass index (kg/m2) 22.83 25.84 29.58
Waist/height ratio 0.45 0.51 0.57
Waist/hip ratio 0.76 0.80 0.85
Body adiposity index 28.22 31.77 36.15
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higher risk to die in comparison to persons in the second
quartile (Table 6). While men in the third and fourth
quartile of BAI had a significantly elevated CVD mortality
risk compared to the reference group there was no associ-
ation between BAI and CVD mortality in women. Increased
WC at baseline also predicted CVD mortality in both sexes.
Compared to the second quartile only men in the fourth
quartile had a significantly elevated CVD mortality risk,
while for women this was found in the third and fourth
quartile.
Anthropometric measures and cancer mortality
The risk to die from cancer increased in women in the
fourth quartile of WC, WHR, and WHtR in comparison
to women in the second quartile. Furthermore, females
in the lowest quartile of WHR had a significantly lower
cancer mortality risk compared to the reference group.
In women there was no association found between BMI
as well as BAI and cancer mortality. A different picture
appeared regarding the association between anthropo-
metric measures and cancer mortality in men. Males in the
bottom quartile of BMI, WC, and WHtR had a significantly
Table 5 Hazard ratios (HR) and confidence intervals (CI) for the
association between the different anthropometric measures and
total mortality for men and women by quartiles; the second
quartile was set as the reference category
Total mortality Men Women
HR 95% CI p-value HR 95% CI p-value
Body mass index
1st quartile 1.18 1.00 1.38 0.044 1.12 0.88 1.43 0.347
2nd quartile 1.00 1.00
3rd quartile 0.91 0.79 1.06 0.213 1.00 0.83 1.21 0.988
4th quartile 1.21 1.06 1.39 0.007 1.29 1.07 1.56 0.007
Body adiposity index
1st quartile 1.12 0.93 1.34 0.250 1.09 0.84 1.42 0.520
2nd quartile 1.00 1.00
3rd quartile 1.02 0.87 1.19 0.822 1.00 0.82 1.21 0.987
4th quartile 1.23 1.06 1.42 0.006 1.18 0.98 1.43 0.085
Waist circumference
1st quartile 1.15 0.97 1.37 0.118 0.98 0.74 1.31 0.904
2nd quartile 1.00 1.00
3rd quartile 0.99 0.85 1.15 0.909 1.22 1.01 1.49 0.043
4th quartile 1.28 1.12 1.47 <.0001 1.63 1.35 1.97 <.0001
Waist to hip ratio
1st quartile 1.04 0.85 1.26 0.717 0.68 0.50 0.93 0.015
2nd quartile 1.00 1.00
3rd quartile 1.12 0.97 1.30 0.119 1.29 1.05 1.58 0.014
4th quartile 1.35 1.17 1.55 <.0001 1.63 1.35 1.97 <.0001
Waist to height ratio
1st quartile 1.34 1.10 1.64 0.004 1.03 0.76 1.40 0.846
2nd quartile 1.00 1.00
3rd quartile 1.16 1.00 1.35 0.054 1.20 0.98 1.47 0.079
4th quartile 1.46 1.27 1.69 <.0001 1.61 1.32 1.95 <.0001
Values are adjusted for age, survey, education level, alcohol intake, smoking
status, physical activity, and time/smoking status interaction
Table 6 Hazard ratios (HR) and 95% confidence intervals (CI) for
the association between the different anthropometric measures
and cardiovascular mortality for men and women; the second
quartile was set as the reference category
Cardiovascular
mortality
Men Women
HR 95% CI p-value HR 95% CI p-value
Body mass index
1st quartile 0.94 0.72 1.22 0.627 1.34 0.91 1.97 0.133
2nd quartile 1.00 1.00
3rd quartile 0.92 0.74 1.16 0.493 1.16 0.86 1.56 0.339
4th quartile 1.30 1.06 1.61 0.013 1.46 1.09 1.97 0.012
Body adiposity index
1st quartile 1.17 0.85 1.60 0.338 0.72 0.46 1.15 0.167
2nd quartile 1.00 1.00
3rd quartile 1.29 1.01 1.66 0.043 0.83 0.62 1.12 0.227
4th quartile 1.54 1.22 1.96 <.0001 1.14 0.86 1.51 0.365
Waist circumference
1st quartile 0.80 0.60 1.08 0.144 1.02 0.64 1.62 0.937
2nd quartile 1.00 1.00
3rd quartile 0.97 0.77 1.21 0.778 1.36 1.01 1.85 0.045
4th quartile 1.28 1.04 1.57 0.018 1.70 1.27 2.28 <.0001
Waist to hip ratio
1st quartile 0.86 0.63 1.18 0.348 0.79 0.50 1.25 0.309
2nd quartile 1.00 1.00
3rd quartile 1.05 0.84 1.31 0.693 1.20 0.88 1.65 0.249
4th quartile 1.33 1.07 1.64 0.009 1.66 1.24 2.22 0.009
Waist to height ratio
1st quartile 0.87 0.61 1.25 0.460 0.82 0.48 1.41 0.476
2nd quartile 1.00 1.00
3rd quartile 1.14 0.90 1.44 0.280 1.23 0.90 1.68 0.196
4th quartile 1.56 1.25 1.94 <.0001 1.62 1.20 2.19 0.002
Values are adjusted for age, survey, education level, alcohol intake, smoking
status, physical activity, and time/smoking status interaction
Table 4 Correlation matrix of the anthropometric measures
(total sample)
BMI BAI WC WHR WHtR
BMI 1.000 0.716 0.808 0.440 0.876
BAI 0.716 1.000 0.354 −0.077 0.633
WC 0.808 0.354 1.000 0.820 0.924
WHR 0.440 −0.077 0.820 1.000 0.710
WHtR 0.876 0.633 0.924 0.710 1.000
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higher risk to die from cancer in comparison to the refer-
ence group. There was no association between BAI as well
as WHR and cancer mortality in men (Table 7).
The association between the different anthropometric
measures and the outcomes all-cause-, CVD-, and cancer
mortality using cubic smoothing splines are shown in Fig. 1
(men) and Fig. 2 (women).
Additional analyses
We also examined the association between BMI and
cause-specific mortality using the WHO cut-off values
(Additional file 1). It was found that men in the BMI
group 25–29.99 kg/m2 had a significantly lower total and
cancer mortality risk; only men with a BMI > = 30 kg/m2
had a significantly elevated CVD mortality risk. In women,
however, there was a significantly increased total, CVD
and cancer mortality risk in the category of a BMI > =
30 kg/m2.
Although there was no significant interaction with age,
additionally age-stratified analysis (cut-off <=60/> 60 years)
were conducted (see Additional file 2, Additional file 3,
Additional file 4).
In the age-group > 60 years all 5 anthropometric mea-
sures were associated with total mortality; persons in the
fourth quartile of the respective measure had an elevated
mortality risk. Only persons in the bottom quartile of
WHR compared to the second quartile had a lower total
mortality risk. Regarding CVD mortality, BMI showed
no association with the outcome; the over 60 years old
persons in the bottom quartile of BAI, WC, WHR, and
WHtR had a significantly lower CVD mortality risk.
Furthermore, persons in the highest quartile of WHtR
compared to the reference group had an elevated CVD
mortality risk. Regarding cancer mortality only partici-
pants in the fourth quartile of BMI and WHtR com-
pared to the reference category had a significantly
elevated risk.
In the age-group <= 60 years, persons in the bottom
quartile of all five measures had a significantly lower
total mortality risk in comparison to the reference
group. Furthermore, participants in the third and fourth
quartile of all five measures (BMI only fourth quartile)
had a significantly elevated total mortality risk in compari-
son to the second quartile; this was also the case with regard
to CVD mortality. Compared to the reference group only
persons in the bottom quartile of WHR and BAI had a
significantly lower CVD mortality risk. Regarding cancer
mortality, persons in the bottom quartile of BMI, WC,
WHR, and WHtR had a significantly lower risk, while
participants in the fourth quartile of BAI, WC, WHR, and
WHtR had a significantly higher risk than the reference
group.
Discussion
Key results
In this population-based cohort study, among the analysed
anthropometric measures BMI, WC, and WHR were
significantly associated with all-cause and CVD-mortality
in men and women. Central obesity seems to reflect
higher mortality risk particularly in women. In men,
WHtR and BAI was found to be strongly and independently
related to all-cause and CVD mortality, respectively. Regard-
ing cancer mortality, a distinct mortality risk pattern turned
out in men and women for the different anthropometric
measures. The adiposity measure BAI may not play a role as
risk predictor for all-cause and cause-specific mortality in
women. All five measures were associated with the different
mortality outcomes in persons <=60 as well as persons >
Table 7 Hazard ratios (HR) and 95% confidence intervals (CI) for
the association between the different anthropometric measures
and cancer mortality for men and women; the second quartile
was set as the reference category
Cancer
mortality
Men Women
HR 95% CI p-value HR 95% CI p-value
Body mass index
1st quartile 1.33 1.02 1.73 0.037 0.93 0.62 1.39 0.715
2nd quartile 1.00 1.00
3rd quartile 0.86 0.67 1.12 0.270 0.85 0.62 1.19 0.347
4th quartile 1.06 0.83 1.36 0.628 1.33 0.97 1.81 0.072
Body adiposity index
1st quartile 1.08 0.79 1.47 0.627 1.20 0.79 1.83 0.395
2nd quartile 1.00 1.00
3rd quartile 0.93 0.71 1.20 0.564 1.14 0.81 1.61 0.445
4th quartile 1.02 0.79 1.31 0.903 1.37 0.98 1.91 0.064
Waist circumference
1st quartile 1.46 1.09 1.95 0.010 0.81 0.50 1.31 0.392
2nd quartile 1.00 1.00
3rd quartile 0.99 0.76 1.30 0.962 1.04 0.74 1.46 0.811
4th quartile 1.24 0.97 1.58 0.088 1.73 1.26 2.36 0.001
Waist to hip ratio
1st quartile 1.25 0.91 1.71 0.172 0.57 0.35 0.94 0.028
2nd quartile 1.00 1.00
3rd quartile 1.03 0.80 1.34 0.805 1.20 0.86 1.66 0.283
4th quartile 1.25 0.98 1.60 0.076 1.39 1.02 1.91 0.039
Waist to height ratio
1st quartile 1.74 1.26 2.39 0.001 0.96 0.59 1.54 0.851
2nd quartile 1.00 1.00
3rd quartile 1.14 0.87 1.48 0.336 1.03 0.73 1.45 0.876
4th quartile 1.25 0.97 1.62 0.084 1.69 1.22 2.34 0.002
Values are adjusted for age, survey, education level, alcohol intake, smoking
status, physical activity, and time/smoking status interaction
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60 years, but the associations were more pronounced and
stronger in the younger age-group.
Body adiposity index as a risk predictor of mortality
The BAI has recently been proposed as an alternative
index of obesity [19]. So far, prospective studies on the
association between BAI as “novel” anthropometric
measure and cause-specific mortality including men and
women from the same population are scarce. In the
present investigation, it was found that BAI was not a
meaningful predictor for total or cause-specific mortality
in women. To the best of our knowledge, no comparable
population-based studies on this issue including women
are available. Thus, this novel finding has to be confirmed
or refuted in further prospective studies. A possible reason
for our finding could be that BAI does not characterise
central obesity, which is associated with higher mortality
risk particularly in females. In addition, studies which inves-
tigated the validity of BAI to reflect body fat percentage
found only a poor concordance [20, 21]. Contrary to
women, in men, BAI turned out to be a good risk predictor
particularly for CVD-mortality in the present study.
Another investigation examining the association between
BAI and all-cause as well as CVD-mortality including
19,756 adult men from Dallas, Texas, reported that BAI is
not a better mortality predictor than BMI or WC [22].
Contrary to the present population-based study, that study
included participants who were referred by their employers
or physicians. Thus, the findings of the studies would not
directly be comparable. An Australian study on 4175 males
free of heart disease, diabetes and stroke from the popula-
tion found that BAI may be of interest as a measure of
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Fig. 1 Association between BMI, BAI, WC, WHR, and WHtR and the outcomes all-cause-, CVD-, and cancer mortality using cubic smoothing splines in men
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obesity but that it was not an independent predictor of
CVD and coronary heart disease mortality [23].
The found association between BAI and CVD mortality
in men was comparable to the associations between the
other investigated general obesity measure BMI and CVD
mortality. Because BAI requires a mathematical calcula-
tion of some complexity, in clinical practice it seems easier
to use the common anthropometric measures such as
BMI to estimate someone’s CVD risk.
Anthropometric measures and all-cause mortality
In the present study BMI showed a u-shaped association
with all-cause mortality in men and women. This pattern
is already well known, for example from a collaborative
analysis of 57 prospective studies, where in both sexes
mortality was lowest at a BMI about 22.5 to 25 kg/m2 [8].
In our study a significantly higher mortality risk from any
cause in the lowest and highest quartiles of BMI were only
shown in men. Waist to hip ratio showed a linear risk
increase through all categories in women. In men,
however, the rise was less distinct. In a meta-analysis
from Czernichow et al. including nine UK cohort studies,
they also found a significant risk increase for rising waist
to hip ratios [9]. In that meta-analysis no testing for sex
differences was reported. A Swedish study including
female participants only showed that obesity does not
seem to be a risk factor for increased mortality as long
as it is not centrally located [24].
The present study showed a significantly elevated
all-cause-mortality risk with increasing WHtR in men,
a finding which corresponds to prior studies on this
issue [16, 25].
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Fig. 2 Association between BMI, BAI, WC, WHR, and WHtR and the outcomes all-cause-, CVD-, and cancer mortality using cubic smoothing splines
in women
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Anthropometric measures and CVD mortality
Central obesity as a risk factor for all-cause and CVD
mortality has been described in a number of other studies
[6, 7, 9]. In our study, central obesity was strongly associated
with CVD mortality, particularly in women. A comparable
study from the Netherlands that also looked for sex differ-
ences in all-cause and CVD mortality did not detect a sex
difference in waist-associated measures [5]. However, they
only considered subjects aged 55 and older, raising the
question if there could be differences regarding the impact
of central obesity on mortality risk in different age-groups.
Further studies underlined that anthropometric measures
of abdominal obesity were strongly and positively associ-
ated with all-cause and CVD-mortality in women [26, 27].
A high WHtR turned out as a significant risk predictor for
CVD mortality in both sexes. This is in accordance with
another study including 16,332 men in the Physicians’
Health Study and 32,700 women in the Women’s Health
Study which demonstrated that WHtR was strongly asso-
ciated with an increased CVD risk (including nonfatal
myocardial infarction, nonfatal ischemic stroke, cardiovas-
cular death) in men and women. Due to the somewhat
different outcomes in the studies, the results are surely
not entirely comparable [28].
Anthropometric measures and cancer mortality
In the present study women with higher WC and WHtR
had a significantly higher risk to die from cancer.
Furthermore, females in the highest quartile of WHR in
comparison to the reference group had a significantly
elevated risk, whereas females in the first quartile had a
lower risk. Contrary, in men lower values of BMI, WC,
and WHtR were significantly related to higher cancer
mortality. Previous studies predominantly looked for
differences in the influence of BMI on cancer mortality.
In addition they were mainly searching for differences
between cancer sites and often did not focus on sex
differences [2, 29]. From these studies it is known that
mortality risk due to obesity differ strongly depending on
the cancer sites. It is remarkable that overweight patients
had a higher mortality risk mainly in hormone-associated
cancers like postmenopausal breast cancer, endometrial
and ovary cancers [29]. This provides us a possible explan-
ation for the higher risk in women with central obesity,
because their cause of death from cancer is more often an
obesity-associated tumour. A study from Zhang et al. also
reported a strongly positive association between abdom-
inal obesity and cancer mortality in women [27]. Contrary,
in men the higher cancer mortality in the bottom quartile
in comparison to the reference group may be due for
example to smoking-related tumours [30].
Other studies have also shown that a more android
fat distribution in women, expressed as a higher WC,
WHtR, and WHR, is associated with a higher risk of
disease [26, 27, 31]. For females, measurements of the
total fat mass of the body, such as BAI and BMI, might
play a more subordinate role in terms of mortality risk.
On the other hand, in men the general overweight and
obesity measures BMI and BAI seems to be suitable as
disease predictors in addition to the measures displaying fat
distribution. BAI and BMI were highly correlated measures
in our study sample and there was a clearer correlation
between these measures and an increased overall and CVD
mortality risk in men compared to women. As underlying
mechanisms for the higher mortality risk associated with a
visceral fat accumulation, particularly in women, a number
of different causes are suggested [32, 33]. For example,
visceral fat is metabolically active with secreting large quan-
tities of proinflammatory cytokines, which could accelerate
the atherosclerotic process and increase the risk of CVD
[34]. The underlying mechanisms for the protective effect
of gynoid and peripheral fat are unknown so far [35].
Furthermore, the mechanisms for the found differences
between men and women are not entirely clear. More
research is needed to elucidate what sex-specific mecha-
nisms with regard to body fat distribution are involved in
disease development.
Strengths and limitations
The main strengths of the present study are the large
sample size with a balanced proportion of men and
women from a population based study and the long
follow-up time of an average of 15 years with a high
number of outcomes. In addition, all anthropometric mea-
sures were collected in a standardized way by trained staff,
which is why we can expect reliable phenotyping. As a
limitation, residual confounding by unmeasured variables
for example dietary factors and comorbidities cannot be
entirely ruled out. When evaluating the relation between
anthropometric measures and mortality, it might be
important to consider lifestyle factors such as diet. A
healthier diet often in combination with a healthier overall
lifestyle is associated with a lower risk of mortality and less
overweight and obesity [36]. Thus, confounding by diet
could have caused the independent effects found in
our study to be overestimated. Furthermore, anthropo-
metric measures were assessed at only one point in
time, so the estimates could not account for changes in
anthropometric measures during follow-up. This study
included German subjects up to an age of 74 at baseline,
thus, risks may differ in older people and persons of
other ethnicity.
Conclusions
In this population based cohort study well established
anthropometric measures such as increased BMI, WC,
WHtR, and WHR were significantly associated with a higher
all-cause and CVD-mortality in men and women. Regarding
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the relationship between common anthropometric measures
and cancer mortality, distinct sex-differences became
apparent. The novel measure BAI seems to play a role
as risk predictor for all-cause and particular CVD mortality
in men only and to be not a useful measure in both sexes
regarding the prediction of cancer mortality.
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